跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
泰特 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Reduced Glutathione for Injection
Approved
化学药品
Reduced Glutathione for Injection
BIOMEDICA FOSCAMA INDUSTRIA CHIMICO-FARMACEUTICA SPA
🇨🇳 National Medical Products Administration
Approval Date
Jun 7, 2023
Approval ID
8TELtwMlK46
Company
BIOMEDICA FOSCAMA INDUSTRIA CHIMICO-FARMACEUTICA SPA
Type
化学药品
Approval Details
Approval Id
8TELtwMlK46
Approval Number
国药准字HJ20181207
Generic Name
注射用还原型谷胱甘肽
Generic Name En
Reduced Glutathione for Injection
Trade Name
泰特
Drug Type
化学药品
Dosage Form
注射剂
Strength
600mg(以C₁₀H₁₇N₃O₆S计)
Reg Date
2023-06-07
Expired Date
2028-06-06
Company Name
BIOMEDICA FOSCAMA INDUSTRIA CHIMICO-FARMACEUTICA SPA
Production Company Name
BIOMEDICA FOSCAMA INDUSTRIA CHIMICO-FARMACEUTICA SPA
Company Detail Path
/organization/biomedica-foscama-industria-chimico-farmaceutica-spa
Production Company Detail Path
/organization/biomedica-foscama-industria-chimico-farmaceutica-spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 7, 2023
Approval ID
8TELtwMlK46
Type
化学药品
Back to NMPA Approvals